Since it began in 1994, TTP Labtech has shown a commitment to innovation, highlighted by its range of products and operational flexibility. Innovation is also apparent in the firm’s staffing. “Out of 100 people, about 75 are in development,” said TTP Labtech Commercial Director Jas Sanghera. The employee-owned, UK-based firm began as a consulting business […]
Company Announcements De Novo Software and ChemoMetec signed a comarketing agreement in October 2011. Nexcelom Bioscience signed a licensing agreement with De Novo Software in October 2011. Partec agreed in November 2011 to sell De Novo Software’s FCS Express software with its CyFlow Cube instrument and to resell the software worldwide. Synthetic biology firm Intrexon […]
The lab equipment market, as defined by IBO, consists of eight categories of techniques. The overall market totaled nearly $2.5 billion in 2011. With a 2012 growth rate of more than 4%, the market is expected to increase by $100 million by the end of 2012. While laboratory equipment of various types is found in […]
Surface zeta potential measurement used to require its own instrument. Now, Malvern Instruments has introduced the Surface Zeta Potential (SZP) cell, an accessory for Malvern’s Zetasizer Nano systems (the Nano Z, Nano ZS or Nano ZS90), which characterize nanoparticles and colloids. The cell allows the measurement of a sample in liquid. The cell began shipping […]
Corning, NY 12/1/11—Corning has acquired Mediatech, including its KD Medical subsidiary, for an undisclosed amount. Mediatech develops, manufactures and sells cell culture media and molecular biology reagents related to tissue and cell culture applications, including products under the cellgro brand. “By providing customers worldwide with greater access to Mediatech’s cellgro product portfolio, this acquisition supports […]
Gothenburg, Sweden 9/15/11; Paris, France 9/15/11; Paris, France 11/2/11; Paris, France 11/4/11—Publicly held genome-engineering firm Cellectis has acquired Sweden’s Cellartis for 1.93 million shares and €16.4 million ($ 22.5 million = €0.73 = $1) in cash. Cellartis is a provider of stem cell–derived products and technologies, including human embryonic stem cell–derived hepatocytes and cardiomyocytes used […]
Company Announcements Seahorse Bioscience appointed In Vitro Technologies as a distributor for Australia and New Zealand and Research Instruments as a distributor for Southeast Asia. IntelliCyt named five new European distributors: Bucher Biotec for Switzerland; Westburg for Benelux and Scandinavia; Grupo Taper for Spain and Portugal; Labtech France; and BioTech for the Czech Republic, Hungary, […]
It is just six months since Pittcon, and IBO’s last review article on new product introductions (see IBO 3/31/11, 4/15/11), and already there is a new and lengthy list of notable new products. In this article, IBO highlights some of the product launches of the last six months based on their potential commercial and technical […]
In what continues to be a busy acquisition period, another set of publicly held analytical instrument companies is set to become one. On September 8, PerkinElmer announced an agreement to acquire Caliper Life Sciences for an estimated $600 million in cash (see page 2). The companies’ complementary product lines and end-markets are a logical combination, […]
Chalfont St. Giles, UK 8/16/11—GE Healthcare has entered into an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and biopharmaceutical and vaccine manufacturing. Financial details were not disclosed. Headquartered in Pasching, Austria, with 215 employees, PAA had 2010 revenues of $55 million. “GE Healthcare Life Sciences is […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
